Renascience Inc. (TYO:4889)
786.00
-48.00 (-5.76%)
Nov 20, 2026, 3:30 PM JST
Renascience Revenue
Renascience had revenue of 68.00M JPY in the twelve months ending September 30, 2026, down -21.84% year-over-year. In the fiscal year ending March 31, 2026, Renascience had annual revenue of 68.00M, down -48.48%. That makes Renascience the 44,721st largest company in the world by revenue and 3,869th in Japan.
Revenue
68.00M
Revenue Growth
-21.84%
P/S Ratio
159.24
Revenue / Employee
n/a
Employees
3
Market Cap
10.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 68.00M | -64.00M | -48.48% |
| Mar 31, 2025 | 132.00M | -62.00M | -31.96% |
| Mar 31, 2024 | 194.00M | 94.00M | 94.00% |
| Mar 31, 2023 | 100.00M | -39.00M | -28.06% |
| Mar 31, 2022 | 139.00M | -70.00M | -33.49% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Ohki Healthcare Holdings | 363.02B |
| Cawachi | 283.28B |
| YAKUODO HOLDINGS | 170.75B |
| Medical System Network | 135.21B |
| Satudora Holdings | 100.33B |
| Pharmarise Holdings | 70.00B |
| Astena Holdings | 69.51B |
| Miahelsa Holdings | 25.32B |